4 min reading time
Privately held Theranos, valued at $9 billion, got a one-two punch of FDA visit and negative WSJ coverage this week. “This is what happens when you work to change things, and first they think you’re crazy, then they fight you and then all of a sudden you change the world,” Holmes said on CNBC. Do you think this is just a story from competitors to discredit the company or is there more here? Story in FierceMedicalDevices: http://ow.ly/TuMPP Michael Salit Jonathan Wacks Yi Dong Stephen Glassic Greg Bearman Burrell (Bo) Clawson Michael Salit Leanna Levine Burrell (Bo) Clawson Now I don’t do spam or irrelevant posts, so I wonder what company’s personnel would consider what I wrote to be spammy content? I wonder what those persons are trying to do, such as to have my posts removed? I wonder if I am the only “spammer” on this thread? Michael Salit Michael Salit Jonathan Wacks Can it work at a price and convenience point to displace big box systems? Well, if they “forgot” to put in a simple filing for a lousy blood container, and blatantly mid-represented their presence in the market, do you really believe this Steve Jobs wannabe? Burrell (Bo) Clawson The question is can Theranos get all the tests done that they claim with a very small sample size. Jonathan Wacks Michael Salit Michael Salit Burrell (Bo) Clawson Burrell (Bo) Clawson Oops, I’ve posted 3 or more times on this subject. Karl Schulmeisters Marked as spam
|